Technical Analysis for VCYT - Veracyte, Inc.

Grade Last Price % Change Price Change
grade C 28.08 2.74% 0.75
VCYT closed down 3.33 percent on Friday, July 12, 2019, on 65 percent of normal volume.

Earnings due: Jul 30

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical VCYT trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 2.74%
Bollinger Band Squeeze Range Contraction 2.74%
20 DMA Support Bullish -0.67%
Bollinger Band Squeeze Range Contraction -0.67%
NR7 Range Contraction -0.67%
Pocket Pivot Bullish Swing Setup -1.44%
Bollinger Band Squeeze Range Contraction -1.44%
20 DMA Support Bullish -0.88%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.88%
Bollinger Band Squeeze Range Contraction -0.88%

Older signals for VCYT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier (GEC), which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. The company is also developing Afirma Malignant GEC test for rare forms of thyroid cancer or metastases to the thyroid that is intended to inform surgical strategy; and idiopathic pulmonary fibrosis and nodules suspicious products for lung cancer. It serves endocrinologists, radiologists, and head and neck specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Organ Systems Gene Expression Lung Cancer Idiopathic Pulmonary Fibrosis Surgeries Glands Thyroid Thyroid Cancer
Is VCYT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 30.25
52 Week Low 8.77
Average Volume 760,879
200-Day Moving Average 18.8944
50-Day Moving Average 25.8854
20-Day Moving Average 27.977
10-Day Moving Average 28.424
Average True Range 1.2718
ADX 18.92
+DI 26.5807
-DI 24.1346
Chandelier Exit (Long, 3 ATRs ) 26.4346
Chandelier Exit (Short, 3 ATRs ) 29.3354
Upper Bollinger Band 29.735
Lower Bollinger Band 26.219
Percent B (%b) 0.32
BandWidth 12.567466
MACD Line 0.6346
MACD Signal Line 0.7902
MACD Histogram -0.1556
Fundamentals Value
Market Cap 926.3 Million
Num Shares 33.9 Million
EPS -0.80
Price-to-Earnings (P/E) Ratio -34.16
Price-to-Sales 3.94
Price-to-Book 5.91
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.94
Resistance 3 (R3) 29.07 28.66 28.67
Resistance 2 (R2) 28.66 28.25 28.60 28.58
Resistance 1 (R1) 28.00 28.00 27.80 27.87 28.49
Pivot Point 27.59 27.59 27.49 27.53 27.59
Support 1 (S1) 26.93 27.18 26.73 26.80 26.17
Support 2 (S2) 26.52 26.93 26.46 26.08
Support 3 (S3) 25.86 26.52 25.99
Support 4 (S4) 25.73